TEK and atherosclerosis: Our previous studies (Del Campo et al., 2019, 2020; Hamczyk et al., 2024) and the results presented here show that EC‐specific progerin expression did not alter any cardiovascular parameter tested in three mouse models (LmnaLCS/LCSTie2Cre, LmnaLCS/LCSCdh5‐CreERT2, and Apoe−/−LmnaLCS/LCSCdh5‐CreERT2) that rely on two different strategies for EC‐specific Cre‐mediated recombination (Tie2 or Cdh5 promoter‐driven), either in atherosclerosis‐free or atheroprone mice (intact versus deleted Apoe gene).